Chr. Hansen Holding A/S (0MR6.L)
| Previous close | 449.94 |
| Open | 448.60 |
| Bid | N/A x N/A |
| Ask | N/A x N/A |
| Day's range | 448.10 - 457.30 |
| 52-week range | 448.10 - 457.30 |
| Volume | |
| Avg. volume | N/A |
| Market cap | 594.536M |
| Beta (5Y monthly) | 0.07 |
| PE ratio (TTM) | 0.09 |
| EPS (TTM) | 47.85 |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- Globe Newswire
Chr. Hansen Holding A/S - Major shareholder announcement from APG Asset Management N.V.
Company announcement no. 6/2022 August 2, 2022 Please see attachment. For further information please contact: Anders Mohr Christensen, Vice President Group Strategy & Investor Relations, Tel: +45 2515 2364 Sanne Seyer-Hansen, Head of Media Relations, Tel: +45 6038 6207 About Chr. Hansen Chr. Hansen is a global, differentiated bioscience company that develops natural ingredient solutions for the food, nutritional, pharmaceutical and agricultural industries. At Chr. Hansen we are uniquely position
- Globe Newswire
Chr. Hansen Holding A/S Interim Report Q3 2021/22
Company announcement no. 05/2022 July 7, 2022 Solid Q3 in an uncertain macroeconomic environment Statement by CEO Mauricio Graber: “The execution of our strategy to differentiate as a focused microbial and fermentation technology company continued to deliver solid results with 9% organic growth for the third quarter 2021/22, equal to 13% growth in EUR terms. Our inflation-driven pricing measures started to contribute positively during Q3, while volume growth slowed down as expected following the
- Globe Newswire
Lillie Li Valeur steps down from the Board of Directors
Company announcement no. 04/2022 April 25, 2022 Please see attachment. For further information, please contact:Anders Mohr Christensen, Vice President Group Strategy & Investor Relations, Tel: +45 2515 2364Annika Stern, Senior Investor Relations Manager, Tel: +45 2399 2382Sanne Seyer-Hansen, Head of Media Relations, Tel: +45 6038 6207 About Chr. HansenChr. Hansen is a global, differentiated bioscience company that develops natural ingredient solutions for the food, nutritional, pharmaceutical an
